Abstract
Background: Caveolin-1 has been shown to be down-regulated in human colon cancer and involved in colon tumorigenesis. We investigated the mechanism. Materials and Methods: Cancerous and nearby non-cancerous tissues of 185 sporadic colorectal cancer samples were enrolled in this study. Methylation-specific PCR was performed to explore the mechanism of regulation of caveolin-1 gene expression. Results: Aberrant promoter methylation in the caveolin-1 gene was 3.8% and 5.9% for cancerous and nearby non-cancerous tissues, respectively. All the cancerous and non-cancerous tissue contained unmethylated promoters in the caveolin-1 gene. The methylation status of caveolin-1 had no clear relationship with age, cell grade, location of tumor or lymph node metastasis. However, female gender showed statistically significant difference (p=0.045). The immunohistochemistry study demonstrated that expression of caveolin-1 correlated with aberrant promoter methylation status in sporadic colorectal cancer tissues. Conclusion: Our findings suggested that aberrant promoter methylation of the caveolin-1 gene may occur at the precancerous stage, regulated by gender-related factors and is associated with gene silencing of caveolin-1 in the development of colorectal cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 1645-1650 |
| Number of pages | 6 |
| Journal | Anticancer Research |
| Volume | 24 |
| Issue number | 3 A |
| Publication status | Published - May 2004 |
Fingerprint
Keywords
- Caveolin-1 gene
- Colorectal cancer
- Methylation specific PCR
ASJC Scopus subject areas
- Cancer Research
- Oncology
Cite this
Promoter CpG methylation caveolin-1 in sporadic colorectal cancer. / Lin, Shyr Yi; Yeh, Kun Tu; Chen, Willian Tzu Liang; Chen, Hung Chang; Chen, Shou Tung; Chang, Jan Gowth.
In: Anticancer Research, Vol. 24, No. 3 A, 05.2004, p. 1645-1650.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Promoter CpG methylation caveolin-1 in sporadic colorectal cancer
AU - Lin, Shyr Yi
AU - Yeh, Kun Tu
AU - Chen, Willian Tzu Liang
AU - Chen, Hung Chang
AU - Chen, Shou Tung
AU - Chang, Jan Gowth
PY - 2004/5
Y1 - 2004/5
N2 - Background: Caveolin-1 has been shown to be down-regulated in human colon cancer and involved in colon tumorigenesis. We investigated the mechanism. Materials and Methods: Cancerous and nearby non-cancerous tissues of 185 sporadic colorectal cancer samples were enrolled in this study. Methylation-specific PCR was performed to explore the mechanism of regulation of caveolin-1 gene expression. Results: Aberrant promoter methylation in the caveolin-1 gene was 3.8% and 5.9% for cancerous and nearby non-cancerous tissues, respectively. All the cancerous and non-cancerous tissue contained unmethylated promoters in the caveolin-1 gene. The methylation status of caveolin-1 had no clear relationship with age, cell grade, location of tumor or lymph node metastasis. However, female gender showed statistically significant difference (p=0.045). The immunohistochemistry study demonstrated that expression of caveolin-1 correlated with aberrant promoter methylation status in sporadic colorectal cancer tissues. Conclusion: Our findings suggested that aberrant promoter methylation of the caveolin-1 gene may occur at the precancerous stage, regulated by gender-related factors and is associated with gene silencing of caveolin-1 in the development of colorectal cancer.
AB - Background: Caveolin-1 has been shown to be down-regulated in human colon cancer and involved in colon tumorigenesis. We investigated the mechanism. Materials and Methods: Cancerous and nearby non-cancerous tissues of 185 sporadic colorectal cancer samples were enrolled in this study. Methylation-specific PCR was performed to explore the mechanism of regulation of caveolin-1 gene expression. Results: Aberrant promoter methylation in the caveolin-1 gene was 3.8% and 5.9% for cancerous and nearby non-cancerous tissues, respectively. All the cancerous and non-cancerous tissue contained unmethylated promoters in the caveolin-1 gene. The methylation status of caveolin-1 had no clear relationship with age, cell grade, location of tumor or lymph node metastasis. However, female gender showed statistically significant difference (p=0.045). The immunohistochemistry study demonstrated that expression of caveolin-1 correlated with aberrant promoter methylation status in sporadic colorectal cancer tissues. Conclusion: Our findings suggested that aberrant promoter methylation of the caveolin-1 gene may occur at the precancerous stage, regulated by gender-related factors and is associated with gene silencing of caveolin-1 in the development of colorectal cancer.
KW - Caveolin-1 gene
KW - Colorectal cancer
KW - Methylation specific PCR
UR - http://www.scopus.com/inward/record.url?scp=3242659130&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=3242659130&partnerID=8YFLogxK
M3 - Article
C2 - 15274335
AN - SCOPUS:3242659130
VL - 24
SP - 1645
EP - 1650
JO - Anticancer Research
JF - Anticancer Research
SN - 0250-7005
IS - 3 A
ER -